Zoetis to Host Webcast and Conference Call on First Quarter 2026 Financial Results

Zoetis Inc. (NYSE: ZTS), the premier animal health company globally, is scheduled to host a webcast and conference call on Thursday, May 7, 2026, at 8:30 a.m. Eastern Time. The session will feature Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph, who will discuss the company’s financial results for the first quarter of 2026 and address inquiries from financial analysts.

Investors and the general public will have the opportunity to access the live webcast and accompanying presentation slides through the Zoetis investor relations website at https://investor.zoetis.com/events-presentations. Pre-registration for this event opens today, and a replay of the conference call will be available following the live broadcast on the same day.

Zoetis, established nearly 75 years ago, focuses on improving animal health and welfare while supporting various stakeholders, including veterinarians, livestock producers, and pet owners across more than 100 countries. The company is dedicated to pioneering health solutions through robust scientific research, innovative drug development, and superior manufacturing processes. Offering a diverse range of products such as medicines, vaccines, diagnostics, and biopharmaceuticals, Zoetis stands at the forefront of the animal health industry.

The company’s mission is underlined by a commitment to innovation and customer satisfaction, with a vision to be the most trusted and valued provider of animal health products. Interested parties are encouraged to tune into the webcast to gain insights into Zoetis’ performance, strategic initiatives, and contribution to animal care. For more information, Zoetis invites visitors to explore its main website at Zoetis.com.

As Zoetis Inc. (NYSE: ZTS) prepares to host its webcast and conference call discussing the first quarter 2026 financial results, investors should approach the event with keen interest, particularly in the context of the broader animal health market. Scheduled for May 7, 2026, at 8:30 a.m. ET, the call will feature insights from CEO Kristin Peck and CFO Wetteny Joseph, which will likely highlight significant trends in Zoetis' financial performance, R&D advancements, and market growth strategies.

Zoetis continues to demonstrate leadership in the global animal health sector, leveraging nearly 75 years of expertise and a robust portfolio that encompasses medicines, vaccines, and diagnostics. With increasing global awareness of animal welfare and health, coupled with a growing pet ownership trend, the company is positioned favorably to capitalize on expanding market demand.

Investors should specifically watch for guidance on revenue growth in key product segments, particularly within vaccines and biopharmaceuticals, as these areas are pivotal for sustaining competitive advantage. Additionally, insights into R&D expenditures and pipeline advancements could provide hints regarding their long-term growth trajectory and innovative capabilities.

Given the best-in-class status of Zoetis, a solid performance in Q1 can be expected, especially considering the ongoing recovery in livestock markets post-pandemic. However, it is prudent to monitor any potential challenges, such as supply chain disruptions or shifts in regulatory landscapes.

For those considering investment, the webcast provides an invaluable opportunity to gauge the company's strategic direction directly from its management. Keeping an eye on market reactions post-call, alongside management commentary, will be essential for informed decision-making in the upcoming days. Access to the live webcast can be found at Zoetis’ investor relations website.